Cargando…

SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines

The world is suffering from the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 uses its spike protein to enter the host cells. Vaccines that introduce the spike protein into our body to elicit virus-neutralizing antibod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suzuki, Yuichiro J., Gychka, Sergiy G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827936/ https://www.ncbi.nlm.nih.gov/pubmed/33440640 http://dx.doi.org/10.3390/vaccines9010036

Ejemplares similares

SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells
por: Suzuki, Yuichiro J., et al.
Publicado: (2021)

gp120 Envelope Glycoproteins of HIV-1 Group M Subtype A and Subtype B Differentially Affect Gene Expression in Human Vascular Endothelial Cells
por: Suh, Andrew J., et al.
Publicado: (2023)

COVID-19 patients may become predisposed to pulmonary arterial hypertension
por: Suzuki, Yuichiro J., et al.
Publicado: (2021)

Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer’s Disease
por: Ding, Qiyue, et al.
Publicado: (2021)

Macaque-human differences in SARS-CoV-2 Spike antibody response elicited by vaccination or infection
por: Willcox, Alexandra C., et al.
Publicado: (2021)

Recombinant subunits of SARS‐CoV‐2 spike protein as vaccine candidates to elicit neutralizing antibodies
por: Noorabad Ghahroodi, Faezeh, et al.
Publicado: (2022)

Spike-directed vaccination elicits robust spike-specific T-cell response, including to mutant strains
por: Stanojevic, Maja, et al.
Publicado: (2022)

Transmission Electron Microscopy Study of Mitochondria in Aging Brain Synapses
por: Rybka, Vladyslava, et al.
Publicado: (2019)

Cross-reactive antibodies elicited to conserved epitopes on SARS-CoV-2 spike protein after infection and vaccination
por: Geanes, Eric S., et al.
Publicado: (2022)

Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines
por: Li, Jianhua, et al.
Publicado: (2021)

Variants of SARS-CoV-2: Influences on the Vaccines’ Effectiveness and Possible Strategies to Overcome Their Consequences
por: Rabaan, Ali A., et al.
Publicado: (2023)

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates
por: Li, Tingting, et al.
Publicado: (2020)

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
por: Shen, Xiaoying, et al.
Publicado: (2021)

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines
por: Shen, Xiaoying, et al.
Publicado: (2021)

Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates
por: Francica, Joseph R., et al.
Publicado: (2021)

Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine
por: Tauzin, Alexandra, et al.
Publicado: (2023)

Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models
por: Huang, Han-Yi, et al.
Publicado: (2022)

SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines
por: Bowen, John E., et al.
Publicado: (2022)

Distinct neutralizing kinetics and magnitudes elicited by different SARS-CoV-2 variant spikes
por: Liu, Yang, et al.
Publicado: (2021)

DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice
por: Prompetchara, Eakachai, et al.
Publicado: (2021)

The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
por: Duan, Liangwei, et al.
Publicado: (2020)

SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
por: Martínez-Flores, Daniel, et al.
Publicado: (2021)

Long-term consequences of SARS-COV2 infection: Long-Covid patterns and possible public health implications
por: Ausín-García, Cristina, et al.
Publicado: (2021)

Long-term consequences of SARS-COV2 infection: Long-Covid patterns and possible public health implications
por: Ausín-García, Cristina, et al.
Publicado: (2021)

Host cell membrane capture by the SARS-CoV-2 spike protein fusion intermediate
por: Su, Rui, et al.
Publicado: (2022)

Spike Glycoprotein and Host Cell Determinants of SARS-CoV-2 Entry and Cytopathic Effects
por: Nguyen, Hanh T., et al.
Publicado: (2021)

Host Cell Membrane Capture by the SARS-CoV-2 Spike Protein Fusion Intermediate
por: Su, Rui, et al.
Publicado: (2023)

A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice
por: Powell, Abigail E., et al.
Publicado: (2020)

Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry
por: He, Yuxian, et al.
Publicado: (2004)

A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice
por: Powell, Abigail E., et al.
Publicado: (2021)

SARS‐CoV‐2 spike trimer vaccine expressed in Nicotiana benthamiana adjuvanted with Alum elicits protective immune responses in mice
por: Song, Shi‐Jian, et al.
Publicado: (2022)

Elicitation of potent neutralizing antibodies in obese mice by ISA 51-adjuvanted SARS-CoV-2 spike RBD-Fc vaccine
por: Li, Chia-Jung, et al.
Publicado: (2023)

The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation
por: Rajah, Maaran Michael, et al.
Publicado: (2022)

SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies
por: Yang, Yang, et al.
Publicado: (2021)

A plant-produced SARS-CoV-2 spike protein elicits heterologous immunity in hamsters
por: Margolin, Emmanuel, et al.
Publicado: (2023)

The Host Interactome of Spike Expands the Tropism of SARS-CoV-2
por: Bamberger, Casimir, et al.
Publicado: (2021)

Evolution of the SARS-CoV-2 spike protein in the human host
por: Wrobel, Antoni G., et al.
Publicado: (2022)

SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies
por: Beukenhorst, Anna L., et al.
Publicado: (2023)

Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes
por: Tada, Takuya, et al.
Publicado: (2021)

Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine
por: Kanduc, Darja, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mkp96m0k9q626rl7bvf9m4cdrc